A 68-year-old Native American housewife who lived on an Indian reservation in Nevada had been under the care of a family practice physician for congestive heart failure (CHF). She had had an acute myocardial infarction (MI) 4 years ago. Left ventricular failure was first noted 18 months ago, and the patient was kept in a compensated state on multidrug therapy until 10 weeks ago when her CHF did not respond to her current regimen. Her medications included digoxin 0.125 mg daily, furosemide 40 mg twice a day, enalapril 20 mg every morning, carvedilol 25 mg twice a day, atorvastatin 20 mg every night at bedtime, ezetimibe 10 mg every night at bedtime, and a salt-poor diet. Physical examination revealed the following: fine moist rales were heard in the right base, there was an S3, S4, a grade 2/4 mitral and a grade 1/4 aortic systolic murmur....
Skip Nav Destination
Article navigation
1 March 2004
Cardiology Casebook|
March 01 2004
The Resurrection of Spironolactone on Its Golden Anniversary
Laurie G. Futterman, ARNP, MSN, CCRN;
Laurie G. Futterman, ARNP, MSN, CCRN
The Division of Cardiology, Department of Medicine, University of Miami School of Medicine, Miami, Fla.
Search for other works by this author on:
Louis Lemberg, MD
Louis Lemberg, MD
The Division of Cardiology, Department of Medicine, University of Miami School of Medicine, Miami, Fla.
Search for other works by this author on:
Am J Crit Care (2004) 13 (2): 162–165.
Citation
Laurie G. Futterman, Louis Lemberg; The Resurrection of Spironolactone on Its Golden Anniversary. Am J Crit Care 1 March 2004; 13 (2): 162–165. doi: https://doi.org/10.4037/ajcc2004.13.2.162
Download citation file:
Sign in
Don't already have an account? Register
Short-term Access
Purchase short-term access on a pay-per-article or pay-per-issue basis.
$15 72 - hour single article access $30 7 - day full issue access